Michigan State University - Breslin Cancer Center — East Lansing, Michigan

Michigan State University - Breslin Cancer Center is a clinical research site located in East Lansing, Michigan, United States 48824-1313.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Michigan State University - Breslin Cancer Center has participated in 2 clinical trials.

Therapeutic areas: Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2).

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Michigan State University - Breslin Cancer Center?

Michigan State University - Breslin Cancer Center has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Michigan State University - Breslin Cancer Center conducted?

Michigan State University - Breslin Cancer Center has 2 clinical trials on record. Their work covers Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2).

Is Michigan State University - Breslin Cancer Center accredited by Crixeo Health?

Michigan State University - Breslin Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Michigan State University - Breslin Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.